| 1371 |
National Cancer Institute |
Html |
en |
Testicular Cancer Screening (PDQ®)–Health Professional Version |
For testicular cancer, there is no standard or routine screening test. Review the limited evidence on the benefits and harms of screening for testicular cancer using ultrasound, physical examination, and self-examination in this expert-reviewed summary. |
| positive predictive value | 0.695776 |
| routine screening | 0.564923 |
| metastatic potential | 0.563198 |
| Anaplastic seminoma accounts | 0.622576 |
| different geographical areas | 0.620061 |
| physical examination | 0.605096 |
| clinical testicular examination | 0.721514 |
| Caucasian populations. | 0.566499 |
| testicular cancer | 0.951907 |
| postnatal risk factor | 0.601402 |
| white men | 0.624527 |
| ethnic groups | 0.563052 |
| testicular cancers | 0.797374 |
| previously impalpable gonad | 0.603117 |
| effective treatments | 0.565355 |
| intermediate incidence rates | 0.604976 |
| American population. | 0.564647 |
| annual increase | 0.563525 |
| dramatic decrease | 0.576242 |
| observed incidence | 0.56787 |
| new cases | 0.568142 |
| appreciable change | 0.564646 |
| testicular self-examination | 0.687127 |
| genetic risk factors | 0.600847 |
|
| single-center case series | 0.602561 |
| U.S. Preventive Services | 0.59719 |
| United States | 0.618395 |
| testicular tumors | 0.686049 |
| pure seminomas | 0.561939 |
| testicular symptoms | 0.684314 |
| common cancer | 0.580765 |
| common malignancy | 0.57065 |
| quasi-randomized controlled trials | 0.594715 |
| Cochrane Collaboration review | 0.593748 |
| asymptomatic population. | 0.565357 |
| routine physical examination | 0.599315 |
| black men | 0.575106 |
| Classic seminoma accounts | 0.61307 |
| Testicular Cancer Treatment | 0.746488 |
| United Kingdom | 0.56682 |
| young men | 0.581551 |
| higher rate | 0.65969 |
| human chorionic gonadotropin | 0.610455 |
| asymptomatic men | 0.627381 |
| testicular ultrasound. | 0.684097 |
| mortality | 0.565405 |
| greater mitotic activity | 0.608461 |
| screening setting | 0.564489 |
|
CLICK HERE |
| 1563 |
National Cancer Institute |
Html |
en |
Intraocular (Uveal) Melanoma Treatment (PDQ®)–Patient Version |
Expert-reviewed information summary about the treatment of intraocular (uveal) melanoma. |
| intraocular melanoma spreads | 0.250336 |
| intraocular melanoma | 0.910343 |
| millimeters | 0.391159 |
| metastatic intraocular melanoma | 0.214724 |
| PDQ cancer information | 0.259005 |
| choroid | 0.268515 |
| clinical trial search | 0.285225 |
| cancer information summary | 0.225998 |
| clinical trial | 0.443006 |
| iris | 0.239636 |
| Gamma Knife therapy | 0.228475 |
| patients | 0.209232 |
| blood vessels | 0.304976 |
| intraocular melanoma tumors | 0.226899 |
| eye | 0.424632 |
| radiation therapy | 0.510988 |
| malignant tumor cells | 0.271535 |
| optic nerve | 0.24596 |
| eyeball | 0.243675 |
| intraocular melanoma forms | 0.241987 |
| small choroid melanoma | 0.211146 |
| treatment | 0.429108 |
| Charged-particle external-beam radiation | 0.231587 |
| intraocular melanoma cells | 0.228349 |
| recurrent intraocular melanoma | 0.212624 |
|
| choroid melanoma | 0.222278 |
| NCI-supported cancer | 0.212728 |
| cancer cells | 0.209946 |
| plaque radiation therapy | 0.308242 |
| small tumor | 0.233192 |
| common eye cancer | 0.210231 |
| treatment clinical trials | 0.228682 |
| National Cancer Institute | 0.24241 |
| new treatment | 0.231582 |
| external-beam radiation therapy | 0.278674 |
| clinical trials | 0.677613 |
| primary tumor | 0.231468 |
| ciliary body | 0.781488 |
| metastatic tumor | 0.244372 |
| medium choroid melanoma | 0.210302 |
| large choroid melanoma | 0.209378 |
| cancer clinical trials | 0.291937 |
| stage | 0.237259 |
| tumor | 0.76237 |
| high-energy sound waves | 0.239767 |
| treatment options | 0.227265 |
| internal radiation therapy | 0.245892 |
| cancer | 0.592755 |
| information | 0.28047 |
|
CLICK HERE |
| 1731 |
National Cancer Institute |
Html |
en |
Oral Contraceptives and Cancer Risk |
A fact sheet about research on the association of oral contraceptive use (birth control pills) with risk of various cancers. |
| oral contraceptives | 0.917263 |
| hereditary ovarian cancer | 0.383854 |
| commonly prescribed type | 0.33973 |
| liver cancer risk | 0.373941 |
| estrogen-progestogen contraceptives | 0.386723 |
| benign liver tumors | 0.371652 |
| risk level | 0.342841 |
| increased risk | 0.351993 |
| time oral contraceptives | 0.52153 |
| ovarian cancer | 0.597198 |
| cervical cancers | 0.357191 |
| birth control pills | 0.477503 |
| cervical cancer | 0.513015 |
| female hormones | 0.362642 |
| hormonal factors | 0.355222 |
| widely used contraceptives | 0.420798 |
| slightly higher risk | 0.352236 |
| oral contraceptive formulations | 0.41375 |
| human papillomavirus | 0.360793 |
| endometrial cancer | 0.391533 |
| Cancer Epidemiology Biomarkers | 0.379203 |
| Cancer Clinical Study | 0.356619 |
| women | 0.413442 |
| study | 0.369792 |
| United States | 0.339309 |
|
| low progestin levels | 0.339553 |
| endometrial cancer risk | 0.376136 |
| oral contraceptive contains | 0.427683 |
| oral contraception | 0.377158 |
| breast cancers | 0.339078 |
| National Cancer Institute | 0.35154 |
| oral contraceptive. | 0.39193 |
| epithelial ovarian cancer | 0.36885 |
| female hormones estrogen | 0.346135 |
| ovarian cancer risk | 0.5032 |
| epidemiological studies | 0.347746 |
| cervical cancer risk | 0.402371 |
| higher risk | 0.352753 |
| hormonal contraceptives | 0.40794 |
| breast cancer risk | 0.408785 |
| protective effect increases | 0.369195 |
| Abstract | 0.338219 |
| breast cancer | 0.500449 |
| malignant liver tumors | 0.371449 |
| birth control pill | 0.342382 |
| cancer risk | 0.531533 |
| et al | 0.421561 |
| New England Journal | 0.388183 |
| cancer | 0.613253 |
|
CLICK HERE |
| 1784 |
National Cancer Institute |
Html |
es |
Complicaciones orales de la quimioterapia y la radioterapia a la cabeza y el cuello (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca de las complicaciones orales, como la mucositis y la disfunción de la glándula salival, que se presentan en pacientes de cáncer tratados con quimioterapia y radioterapia a la cabeza y el cuello. |
| Cancer Inst Monogr | 0.239559 |
| Schubert MM | 0.377541 |
| cuidado dental | 0.263915 |
| Oral complications | 0.73133 |
| oral involvement | 0.311957 |
| Hong CH | 0.250225 |
| Stem Cell Transplantation | 0.260042 |
| tóxicos orales agudos | 0.296836 |
| infecciones vÃricas tardÃas | 0.240097 |
| mucosa inmunidad | 0.238568 |
| oral cryotherapy | 0.302117 |
| Oral Care Study | 0.325881 |
| efectos tóxicos directos | 0.264484 |
| oral básica | 0.298176 |
| cell transplantation | 0.36439 |
| Epstein JB | 0.250634 |
| hematopoietic cell transplantation | 0.356137 |
| Oral Dis | 0.304725 |
| Oral Oncology | 0.315424 |
| patients treated with | 0.256291 |
| oral sistemática | 0.403576 |
| Pretreatment oral assessment | 0.299848 |
| cáncer causa efectos | 0.235719 |
| células madre | 0.562689 |
| oncologÃa oral | 0.303702 |
|
| Cancer Quality | 0.23962 |
| Care Cancer | 0.911761 |
| Brennan MT | 0.291094 |
| Oral biofilms | 0.300769 |
| Johnson BS | 0.249495 |
| recuperación hematopoyética infecciones | 0.23764 |
| Oral Oncol | 0.388386 |
| EICH oral aguda | 0.30451 |
| quimioterapia mielosupresora | 0.237026 |
| Dowd FJ | 0.255583 |
| Pathol Oral Radiol | 0.29984 |
| Complicaciones Citas | 0.24913 |
| patients receiving | 0.238033 |
| Sonis ST | 0.246364 |
| Peterson DE | 0.312811 |
| Mosby Elsevier | 0.254331 |
| Surg Oral Med | 0.300003 |
| systematic review | 0.853357 |
| 6th ed | 0.252103 |
| dental extractions | 0.245651 |
| Yagiela JA | 0.254334 |
| Oral Maxillofac Surg | 0.292509 |
| cuidado oral | 0.503096 |
| oral citotoxicidad | 0.308917 |
|
CLICK HERE |
| 2010 |
National Cancer Institute |
Html |
es |
Grados de comprobación científica de los estudios de investigación sobre detección y prevención del cáncer (PDQ®)–Versión para profesionales de salud |
Información acerca de cómo evaluar la solidez de los datos probatorios obtenidos en los estudios de investigación sobre detección y prevención del cáncer. |
| Woolf SH | 0.300601 |
| Helfand M | 0.300564 |
| sección datos | 0.302661 |
| Current methods | 0.300631 |
| importancia clÃnica | 0.300524 |
| Consejo editorial usa | 0.301821 |
| datos probatorios indirectos | 0.302664 |
| Prev Med | 0.300645 |
| beneficios opción | 0.300848 |
| National Cancer Institute | 0.300824 |
| medida estudios | 0.300552 |
| Preventive Services Task | 0.303591 |
| Instituto Nacional | 0.30261 |
|
| Visuals Online | 0.300487 |
| intervenciones invasoras | 0.300666 |
| Harris RP | 0.300578 |
| Physician Data Query | 0.300891 |
| Services Task Force | 0.303562 |
| datos probatoriosUn estudio | 0.301838 |
| posibles beneficios | 0.30077 |
| datos probatorios | 0.994126 |
| acuerdo vs | 0.301691 |
| participantes vs | 0.301672 |
| US Preventive Services | 0.301 |
| perjuicios opción | 0.301319 |
| mejores estudios | 0.300602 |
|
CLICK HERE |
| 2076 |
National Cancer Institute |
Html |
es |
Alcohol y el riesgo de cáncer |
Hoja informativa que resume la comprobación de la relación entre el consumo de alcohol y el riesgo de varios cánceres. Incluye información de los factores que afectan el riesgo de cánceres asociados con el alcohol, como son los genes y el uso de tabaco. |
| Neck Cancer Epidemiology | 0.538614 |
| Lancet Oncology | 0.534891 |
| Hirose K | 0.511352 |
| Matsuo K | 0.510531 |
| levadura fermenta azúcares | 0.523222 |
| pharyngeal cancers | 0.510877 |
| Alcohol drinking cessation | 0.626157 |
| British Journal | 0.511017 |
| vitamina a | 0.51094 |
| Straif K | 0.510855 |
| vitamina e | 0.511443 |
| IARC Monographs | 0.512402 |
| IARC Working Group | 0.518509 |
| riesgos resultantes | 0.517271 |
| Estados Unidos | 0.591854 |
| alcohol drinking | 0.759868 |
| Tajima K | 0.511125 |
| PubMed Abstract | 0.957874 |
| neck cancers | 0.610459 |
| Cancer Epidemiology | 0.551257 |
| Beral V | 0.510723 |
| Liver Disease | 0.511887 |
| cancer prevention | 0.54975 |
| alcohol consumption with | 0.621668 |
| vino tinto | 0.531211 |
|
| results from subgroup | 0.518268 |
| International Head | 0.510721 |
| Fedirko V | 0.510662 |
| contaminantes cancerÃgenos | 0.510849 |
| Carcinogenic Risks | 0.530612 |
| ADH hiperactiva | 0.535244 |
| Numerosos estudios | 0.516257 |
| preclinical studies | 0.511192 |
| enzima hiperactiva | 0.522144 |
| Bonifazi M | 0.510536 |
| epidemiological studies | 0.512501 |
| Hodgkin lymphoma | 0.511109 |
| enzima adh hiperactiva | 0.532963 |
| Tramacere I | 0.552596 |
| genetic polymorphisms | 0.530043 |
| enzima llamada | 0.519065 |
| Bagnardi V | 0.51066 |
| Rehm J | 0.529488 |
| cabo estudios | 0.515059 |
| pooled analysis | 0.527827 |
| renal cell carcinoma | 0.521274 |
| Cancer Institute | 0.525901 |
| células renales | 0.53114 |
| New York Academy | 0.514614 |
|
CLICK HERE |
| 2956 |
National Cancer Institute |
Html |
en |
Stress and Smoking |
Many people smoke when they feel stressed. A major part of quitting smoking is finding ways to handle your stress. Get tips on ways you can reduce stress in your life. |
| mood | 0.321745 |
| yoga | 0.311766 |
| smokers | 0.257588 |
| effective—like | 0.254092 |
| body | 0.252396 |
| short walk | 0.459288 |
| lowers | 0.345038 |
| ways | 0.478317 |
| problem | 0.256426 |
| solution | 0.253633 |
| smoking | 0.723433 |
| things | 0.251219 |
| nicotine feel | 0.464166 |
| healthy ways | 0.416006 |
| oxygen | 0.318701 |
| quitting | 0.25513 |
|
| unpleasant feelings | 0.498181 |
| stress | 0.995674 |
| relaxation exercise | 0.463458 |
| cigarette | 0.258889 |
| emotions | 0.253066 |
| withdrawal | 0.2602 |
| Nicotine addiction | 0.459283 |
| brain | 0.303202 |
| people | 0.263655 |
| long-term stress reliever | 0.883552 |
| calms nerves | 0.742794 |
| cigarettes | 0.42465 |
| depression | 0.30341 |
| time | 0.25441 |
| better ways | 0.410713 |
| Cravings | 0.267404 |
|
CLICK HERE |
| 3932 |
National Cancer Institute |
Html |
es |
Aprenda a relajarse |
Ejercicios de relajación y de visualización para ayudar a reducir el dolor y el estrés del cáncer y de su tratamiento. |
| pequeña almohada | 0.868399 |
|
| agradable sensación | 0.763417 |
|
CLICK HERE |
| 17277 |
National Cancer Institute |
Html |
null |
Cáncer avanzado y quienes cuidan |
Si usted cuida a un paciente, puede sentir cansancio y preocupación a medida que se enfrenta al cáncer de su ser querido. Cuidar a alguien con cáncer avanzado trae desafíos y preocupaciones nuevas. |
|
|
CLICK HERE |
| 17288 |
National Cancer Institute |
Html |
es |
Personal de atención para la salud |
Información sobre el equipo de tratamiento de proveedores de salud que trabajan juntos para ayudar a pacientes con cáncer. |
| cuáles alimentos | 0.989407 |
|
|
CLICK HERE |